Fresenius revisits market it began for €500m equity-neutral CB hit
Fresenius, the German healthcare company that launched the first equity-neutral convertible bond in 2014, returned on Thursday to issue another successful deal, this time to complete the financing of its €5.76bn acquisition of Quirónsalud, the Spanish hospitals group.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: